PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “MASS SCREENING TECHNICS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 415 records · Page 23Linked to original sources

Cervical cancer in the asian pacific-epidemiology, screening and treatment.

Squamous cell carcinoma (SCC) of the cervix continues to be a major problem in many areas of the Asian-Pacific, particularly in the Indian subcontinent and Papua New Guinea, and to a lesser extent in South-East Asia, Korea and Mongolia. In contrast, levels in the developed countries of the region are low, as is also the case for the Muslim countries of Western Asia, and mainland China. Incidence generally mirrora associated mortality, although with some exceptions reflecting facilities and infrastructure for early detection. Over the last 25 years there has been a marked decrease in incidence rates across most of the Asian Pacific, although less pronounced in India than elsewhere, and there are exceptions where the incidence is on the increase. The predominant risk factor is well established to be persistent infection with a high risk 'oncogenic' type of human papilloma virus (HPV), along with multiple partners, other sexually transmitted diseases and smoking. Consumption of vegetables, in contrast, appears to be protective. Hormonal factors may also play some role. Modifying factors may either impact on neoplasia by directly influencing the processes underlying carcinogenesis, or indirectly by affecting persistence of viral infections. For primary prevention, avoidance of repeated infections and smoking, as well as a high antioxidant intake may be beneficial. Vaccines against HPV also have promise for the future, but a better understanding of the mechanisms underlying spontaneous clearance of both infection and cervical intraepithelial neoplasia (CIN) of different grades is also essential for optimal intervention. For screening, the choice of whether the PAP smear, HPV testing or some form of visual inspection are utilized depends on the resources which are available, all approaches having their own advantages and disadvantages, but with similar sensitivity and specificity. One complication is the increase in adenocarcinoma of the cervix which has been reported in some countries, for which risk factors and most effective screening may differ from the SCC case. A focus on high risk groups like sex workers might be warranted where financial and technical support are limited. If cervical intraepithelial neoplasias are detected then cryotherapy or the loop electrosurgical excision procedure (LEEP) are effective for their removal. Control of cancer of the cervix, however, demands that a comprehensive approach to screening and management is adopted, necessitating major training of personnel and provision of appropriate resources.

Asia↗

Hearing loss in early infancy: incidence, detection and assessment.

Auditory evoked potential techniques have revitalized programs for early detection, quantification, and management of hearing loss. Some issues underlying the need for such programs, and their structure, are reviewed with reference to recently-published guidelines. The prevalence of hearing loss in infancy is poorly understood; estimates depend on the type and degree of loss, the tests used, and their timing. Evidence that significant hearing loss can escape early detection continues to accumulate; delays are attributable to many factors, including insufficient awareness and deficiencies in conventional tests. High-risk registers are valuable but imperfect tools, and should not be the sole avenue of early detection. Electrophysiologic tests, especially the auditory brain stem response, have a major role in early assessment. Attention to many technical and patient-related factors is required, and frequency-specific testing is feasible and informative.

Age Factors↗

Screening mammography: a successful public health initiative.

This paper reviews the ability of screening mammography to reduce breast cancer death rates, and it discusses methods that maximize benefits and reduce false-positive interpretations in a screening program. The review covers published results from screening mammography programs conducted in Europe and North America, along with quality assurance measures designed to ensure that similar or even better outcomes will be shared by other populations of screened women. Randomized trials in Europe and the United States of America have shown the benefit from screening women ages 40-70 years. Encouraged by the success of these trials, many Scandinavian countries now offer screening mammography to their populations as a public health service. These service screening programs have reduced breast cancer deaths as much as 63% among women who were screened. In the United States, where 61.5% of women age 40 and older report having had a mammogram in the preceding year, death rates from breast cancer have been falling despite an increasing incidence of the disease. The technical quality of mammography in the United States has improved as a result of advances in mammography equipment, including the film-screen systems. Also contributing to the improvement has been the implementation of federally mandated quality control testing at each mammography facility, as required by the Mammography Quality Standards Act (MQSA), which the Congress of the United States approved in 1992. Factors that result in increased detection of early-stage cancers include better technique, use of two mammographic views per breast, annual screening intervals, and improved interpretation. Mammography is one of the 10 major subject categories on the American Board of Radiology examinations. Furthermore, MQSA requires radiologists who practice mammography to obtain continuing medical education credits and to use standard interpretation assessments on every report. Manuals for technical quality control and breast imaging reporting, as well as education and self-assessment materials on interpretation, have been developed by the American College of Radiology. Even though mammography will not detect all breast cancers, it is still the best available screening test. The American Cancer Society recommends that annual screening mammography begin no later than age 40 years.

Breast Neoplasms↗

An open Internet platform to distributed image processing applied to dermoscopy.

Proprietary systems for dermoscopy images analysis are available to improve the diagnosis and follow-up of the pigmented skin lesions. Their performance seems comparable with that of a human expert. Progress in computer-aided classification of melanocytic lesions depends notably on judicious choices of the algorithms dedicated to the extraction of signs from the dermoscopy images and of the method which combines these signs to classify the lesions. To allow the researcher's community to benefit from their large set of elementary algorithms already available for dermoscopy, we set up a system accessible through the Internet which: allows the engineers to register their algorithms while preserving their secrecy: their programs run on their own server; lets a user to define its own sequence of image analysis and to apply it to its images: the system automatically calls the appropriate remote programs; makes possible and stimulates the synergy of worldwide researchers in order to validate algorithms of images analysis best suited to achieve the correct diagnosis and to track the malignant melanoma; makes these techniques available to the greatest number of users through the Web and thus to support a mass screening; reduces the maintenance of the system to the minimum: it requires users only an Internet browser and engineers to follow a simple widespread standardised interface for distributed programs. Various problems should be addressed: the lack of standardisation of images acquisition: algorithms based on relative colours are best suited to this system; the copyrights on images and algorithms; charging the use of remote computer resources. This system allows for an international collaborative work in the fight against the malignant melanoma by offering a conceptual and technical platform of teledermoscopy. It is intended to support synergy between the engineers and the users implied in the diagnosis and teaching of dermoscopy.

Algorithms↗

Breast cancer screening. Interpreting new data for clinical practice.

While multiple trials support routine mammography for women aged 50 to 69 demonstrating a reduction in breast cancer deaths by about 30%, experts disagree on breast cancer screening recommendations for women 40 to 49 years old. A review of the data and its interpretation illustrate the areas of controversy: lack of statistical power, prolonged screening intervals, suboptimal mammographic technical quality, and difficulty applying the data to current mammographic screening practice. Clinical decision making for health care providers and women aged 40 to 49 is guided by understanding the risk of breast cancer and weighing the risk and benefits of screening mammography. Further research to resolve whether breast cancer screening is effective in decreasing breast cancer deaths in women aged 40 to 49 is needed.

Adult↗

[Comparison of blood sugar measured by Hoffman's, glucose oxidase and dextrostix technics during the oral glucose tolerance test].

The venous blood sugar has been measured in 384 adult subjects, between 20 and 60 years if agem during two oral glocose tolerance tests, with three methods: Hoffman's method, Glucose-oxidase method, and assay with reflectance meter (DRM). A good correlation was found with all methods (erg = 0,6 at 60 mn after load); however, the results given by the DRM were lower. So, in spite of its practical and economical advantages, the DRM can neverbe used for the diagnosis of an anomaly in the OGTT results. This method is a good one in emergency situations and in mass screening for diabetes.

Adult↗

Tuberculosis control in Kyrgyzstan--an opportunity.

Tuberculosis incidence and mortality rates are rising steeply, reflecting economic hardship and the deterioration of the health infrastructure. The human and technical resources needed to reverse this trend are on hand, but cannot be used effectively without an adequate financial input. The cost of controlling tuberculosis now is modest compared with the cost of allowing it to increase.

Humans↗

Antibody screening in a population of children.

The first large-scale (secondary) intervention trials have been initiated in first-degree family members of patients with insulin-dependent diabetes mellitus (IDDM). Within a few years, data from these studies may suggest that intervention is possible, thereby opening similar approaches in the general population. However, before large-scale intervention studies can be initiated, several problems need to be solved. One of these problems is the lack of knowledge on the natural course of beta-cell autoimmunity. This review analyses this and other issues related to population-based prediction for IDDM. At present, no long-term follow-up studies are available in large-sized populations, but data show that prediction in the general population is both technically feasible and likely to have sufficient power to be useful in prevention trials. More data need to be generated, not only to determine which markers are most likely to give good prediction but also to obtain knowledge on the natural course, psychosocial impact and cost-effectiveness of screening.

Autoantibodies↗

[Evaluating risk of morbidity among workers of coal open-cast mines in Kuzbass].

Work conditions on open-cast minest of Kuzbass include complex of unfavorable natural climate, mining technical occupational factors (microclimate, industrial noise, vibration, aerosols, toxic chemicals, hardiness and intensity of work). According to those occupational factors, the authors calculated risks of morbidity and safe length of service.

Adult↗

Effectiveness and patient satisfaction with screening flexible sigmoidoscopy performed by registered nurses.

BACKGROUND: Our aim was to compare the effectiveness and patient satisfaction with flexible sigmoidoscopy performed by a registered nurse, general surgeons, and gastroenterology fellows. METHODS: Consecutive outpatients referred for sigmoidoscopy were assigned to have the procedure performed by the first available provider. Depth of insertion of the sigmoidoscope, complications, duration of the procedure, and percentage of patients with adenomas were recorded. After the procedure, patients completed a validated patient satisfaction questionnaire. RESULTS: Mean depth of insertion was less for general surgeons compared with the nurse and gastroenterology fellows (50 vs 53 vs 54 cm, respectively; p = 0.01). Mean duration of procedure was longer for the nurse compared with general surgeons and gastroenterology fellows (8.3 vs 7.6 vs 6.8 min, respectively; p = 0.0001). Percentage of patients with adenomas was similar among patients who underwent sigmoidoscopy by the endoscopists (7% vs 8% vs 9%; p = 0.81). No differences were detected between endoscopists for overall satisfaction (p = 0.60), technical skills of the endoscopist (p = 0.58), communication skills of the endoscopist (p = 0.61), or interpersonal skills of the endoscopist (p = 0.59). CONCLUSION: No clinically significant differences in effectiveness or patient satisfaction were detected with flexible sigmoidoscopy performed by a registered nurse, general surgeons, or gastroenterology fellows.

Adult↗

[Cause and follow-up of inadequate cervical smears in the county of Funen].

BACKGROUND: Inadequate cervical smears cause repetition of sampling, which is both costly and a cause of concern to the patient. The objective of this study was to examine why cervical smears were classified as inadequate and to elucidate the underlying diagnoses in order to make recommendations on how to improve smear quality and the interpretation of the sample. MATERIALS AND METHODS: We investigated 2113 inadequate smears from the screening population in the County of Funen and they were classified according to the cause of inadequacy and the final diagnoses. Smears without endocervical cells (ECC) were classified as inadequate. In the study period a total number of 35,628 smears were taken. RESULTS: Most smears were inadequate because of the lack ECC, but inflammatory changes and poor technical quality also contributed. Two cases of cervical cancer and 31 cases of cervical intraepithelial neoplasia were found at follow-up. DISCUSSION: The results indicate that inadequate smears generally conceal benign diagnoses. However, it is still important to reduce the number and to secure follow up, as we found 31 cases of cervical intraepithelial neoplasia and two cervical cancers. Recommendations for obtaining a better smear quality, including the implementation of liquid-based cytology, are given.

Adult↗

The prevalence of hepatitis B surface antigen in the Gezira (Sudan).

The prevalence of hepatitis B surface antigen (HBsAg) was studied in blood donors and laboratory technical staff from the Gezira area in Sudan. Of a total of 110 donors, 19 (17.3%) were found to be carriers of the antigen and 4 of 33 (12.1%) technical staff were also found to be carriers. Routine testing of blood donors is recommended as a way of reducing the incidence of post-transfusion hepatitis in the Gezira area of Sudan.

Adult↗

Diagnostic value of the glycerol lysis test.

The diagnostic value of the standard glycerol lysis test (GLT) has been evaluated by studying 95 cases of hereditary spherocytosis (HS), 513 beta- and 25 alpha-thalassemia trait (Th) carriers, 170 iron-deficient patients (ID), and 217 patients with miscellaneous hematological conditions. The sensitivity of the test, at 95% specificity, was 97% for beta-Th, 53% for ID, and only 36% for HS, so that the predictive value of a positive result is practically nil for HS, 50% to 85% for Th, and 10% to 35% for ID, depending on the prevalence ratio of the disease in the examined population. The technical variability of GLT, explored by a proper experimental design, was found to be rather high, its main components being repeatability and variability of reagent preparations. The dependence of the results on operators was negligible. It is concluded that GLT is not suitable as a laboratory test for the detection of abnormalities in red cell osmotic fragility because of its very low sensitivity toward increased fragility. For decreased red cell osmotic fragility, the sensitivity of GLT is high; however, it is less valuable than the traditional 0.35% NaCl method as mass screening test for the detection of beta-Th, giving more false positive results.

Analysis of Variance↗

Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assay.

BACKGROUND: A NAT was developed (Procleix multiplex, Chiron Corporation) to simultaneously detect HIV-1 and HCV RNA with multiplex transcription-mediated amplification (mTMA) on pooled or single donations. HIV-1 and/or HCV RNA discriminatory probes confirm infection and discriminate the virus type. When a multiplex reactive sample does not react in discriminatory assays, the result is considered nondiscriminated reactive (NDR) and the donor status is uncertain. This study was designed to determine the clinical significance of NDR results. STUDY DESIGN AND METHODS: Three years of donor NAT and serology results were reviewed to determine HCV and HIV-1 infection rates as well as NDR events. Index NDR and seronegative donations were retested by mTMA and serology. Follow-up samples were tested by serology, mTMA, and PCR (selected samples). RESULTS: From April 1999 through April 2002, 5.1 million donations were screened with Procleix HIV-1 and HCV mTMA. The observed NDR rate declined from 0.014 percent (1 in 7242) to 0.0053 percent (1 in 18,795). None of the 462 donors with index NDR donations and additional NAT and serology data (from 724 donation and follow-up samples) were found infected. CONCLUSION: In most NDRs, the original mTMA reactivity is not reproducible and likely related to technical errors (mTMA cross-contamination). The retest and clinical follow-up data, combined with published evidence that the two discriminatory assays have the same sensitivity as multiplex HIV-1 and HCV, support the recommendation that donors with an NDR result for whom the multiplex reactivity cannot be reproduced should either not be notified or be deferred or should be counseled that they are not infected and expeditiously reinstated.

Blood Donors↗

An integrated strategy for the process development of a recombinant antibody-cytokine fusion protein expressed in BHK cells.

Recombinant fusion proteins offer important new therapeutic approaches for the future. This report describes the use of three different genetic strategies (i.e. "mono-", "bi-" and "tri-cistronic" vectors) to achieve stable secretion from BHK cells of a glycosylated antibody-cytokine fusion protein designed for use in antitumour therapy. It describes selection of a robust and effective production cell line based on stability of secretion of the product, quality of mRNA and protein products and performance in in vitro bioassays for potency. The data obtained at this stage were utilised in the selection of a suitable candidate production cell line. The relative productivity and general performance of the cells in stirred tank and fixed bed culture systems indicated that a variety of cell culture technologies provided robust tools for production of a highly selected cell clone. Consistency of the product glycosylation was determined by analysis of released oligosaccharides using matrix-assisted laser desorption ionisation-time of flight mass spectrometry and high-performance anion exchange chromatography. These investigations showed consistent expression of three glycoforms of the fusion protein which varied in their relative proportions in different culture systems and at different time points in a fixed bed reactor with continuous perfusion. In conclusion, this study dealt with a range of important scientific and technical issues which are essential for regulatory approval and commercial success of a recombinant protein and elucidates some useful markers for process development for similar recombinant biologicals.

Animals↗

Molecular diagnostics in virology.

Molecular biology has significantly improved diagnosis in the field of clinical virology. Virus discovery and rapid implementation of diagnostic tests for newly discovered viruses has strongly beneficiated from the development of molecular techniques. Viral load and antiviral resistance or subtyping assays are now part of the biological monitoring of patients chronically infected by human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) and CMV. It will be important to add to this panel assays for other viruses of the herpesviridae family. Qualitative assays for the detection of blood-borne viruses have increased safety of blood donation and organ transplantation. Screening of other blood-borne viruses (parvovirus B19, HAV), multiplexing of detection and test automation to improve practicability and reduce costs will be the next steps. A major evolution in the near future will be the generalization of NAT for the diagnosis of viral etiology in patients, mostly with respiratory, CNS or gastro-intestinal diseases. Major technical improvements have been made to avoid obstacles that still limit this generalization, i.e. genetic variability of viruses, multiplex detection, contamination risk. Commercial offers already exist but menus must be extended to limit the validation and documentation work associated with home-brew assays. Real-time amplification has allowed the development of new NAT platforms but automation and integration of all steps of the reaction are still required to reduce hands-on-time, time-to-result and costs, and to increase throughput.

Antibodies, Viral↗

CT colonography (virtual colonoscopy) for the detection of colorectal polyps and neoplasms. current status and future developments.

Computed tomography colonography (CTC) is a new, rapidly developing non-invasive CT technique used to detect colonic polyps and cancers. It employs two- (2D) and three-dimensional (3D) images of the colon in order to display neoplastic lesions. Clinical trials demonstrate promising results for the detection of polyps and cancers greater than or equal to 10 mm in size. Our purpose is to describe the technique of CT colonography, review recent published trials of CT colonography, and elucidate current clinical applications. Continuing technical innovations such as multidetector CT, computer-aided diagnosis, new image display techniques and faecal tagging promise to improve the performance and patient acceptance of CT colonography in the future.

Adenomatous Polyposis Coli↗